|
Synonyms: ALN-TTRsc04
Compound class:
Nucleic acid
Comment: Nucresiran (ALN-TTRsc04) is a small interfering RNA (siRNA) that is designed to target transthyretin (TTR) mRNA to reduce TTR expression. To improve pharmacokinetics, the nucleotides are chemically modified (2'-O-methyl/2'-MOE and 2'-deoxy-2'-fluoro/2'-F monomers), with a mixed phosphorothioate/phosphate backbone, and it has a N-acetylgalactosamine (GalNAc) modified forward strand 5' end ("R" in the sequence provided) to enhance hepatic delivery via binding to liver-expressed asialoglycoprotein receptors (ASGRs).
|
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | siRNA |
| Target | transthyretin (TTR) mRNA |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12909 | nucresiran |
Synonyms ![]() |
| ALN-TTRsc04 |
Database Links ![]() |
|
| CAS Registry No. | 2847913-45-3 (source: WHO INN record) |
| Search PubMed clinical trials | nucresiran |
| Search PubMed titles | nucresiran |
| Search PubMed titles/abstracts | nucresiran |